{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:13:16Z","timestamp":1790190796833,"version":"4.1.0"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,19]],"date-time":"2015-03-19T00:00:00Z","timestamp":1426723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Prinses Beatrix Fonds","award":["WAR08-12"],"award-info":[{"award-number":["WAR08-12"]}]},{"name":"Netherlands Organization for Scientific Research","award":["916.10.148"],"award-info":[{"award-number":["916.10.148"]}]},{"name":"Brain Foundation of the Netherlands","award":["FS2008(1)-28"],"award-info":[{"award-number":["FS2008(1)-28"]}]},{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","award":["15853"],"award-info":[{"award-number":["15853"]}],"id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003448","name":"Greek General Secretariat of Research and Technology","doi-asserted-by":"crossref","award":["1154"],"award-info":[{"award-number":["1154"]}],"id":[{"id":"10.13039\/501100003448","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004923","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["186874"],"award-info":[{"award-number":["186874"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003157","name":"Myasthenia Gravis Foundation of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003157","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R24EY014837"],"award-info":[{"award-number":["R24EY014837"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.expneurol.2015.03.010","type":"journal-article","created":{"date-parts":[[2015,3,26]],"date-time":"2015-03-26T15:24:58Z","timestamp":1427383498000},"page":"18-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors \u2014 Recommendations for methods and experimental designs"],"prefix":"10.1016","volume":"270","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9761-0002","authenticated-orcid":false,"given":"Mario","family":"Losen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Martinez-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Molenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Lazaridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Socrates","family":"Tzartos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talma","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Sheng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Lindstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Kusner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2015.03.010_bb0005","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1096\/fasebj.14.1.185","article-title":"A peptide vaccine that prevents experimental autoimmune myasthenia gravis by specifically blocking T cell help","volume":"14","author":"Araga","year":"2000","journal-title":"FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0010","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.4049\/jimmunol.180.4.2132","article-title":"Ex vivo generated regulatory T cell s modulate experimental autoimmune myasthenia gravis","volume":"180","author":"Aricha","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0015","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaut.2010.12.001","article-title":"Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis","volume":"36","author":"Aricha","year":"2011","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0020","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1006\/clin.1993.1071","article-title":"Regulation of antibody production by helper T cell clones in experimental autoimmune myasthenia gravis is mediated by IL-4 and antigen-specific T cell factors","volume":"67","author":"Asthana","year":"1993","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0025","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.4049\/jimmunol.172.4.2697","article-title":"Breakdown of tolerance to a self-peptide of acetylcholine receptor alpha-subunit induces experimental myasthenia gravis in rats","volume":"172","author":"Baggi","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0030","first-page":"223","article-title":"Experimental myasthenia gravis is inhibited by receptor\u2013antireceptor complexes","volume":"7","author":"Barkas","year":"1982","journal-title":"J. Clin. Lab. Immunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0035","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/archneur.1980.00500590087016","article-title":"Steroid treatment for experimental autoimmune myasthenia gravis","volume":"37","author":"Barone","year":"1980","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0040","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1084\/jem.151.1.204","article-title":"Experimental myasthenia gravis. A murine system","volume":"151","author":"Berman","year":"1980","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0045","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.4049\/jimmunol.140.10.3406","article-title":"Resistance to experimental autoimmune myasthenia gravis in genetically inbred rats. Association with decreased amounts of in situ acetylcholine receptor\u2013antibody complexes","volume":"140","author":"Biesecker","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0050","first-page":"263","article-title":"Prevention of experimental autoimmune myasthenia gravis in rats by fetal alpha-fetoprotein-rich fractions","volume":"5","author":"Brenner","year":"1984","journal-title":"Tumour Biol.: J. Int. Soc. Oncodevelopmental Biol. Med."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0055","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1096\/fj.02-0609com","article-title":"The role of readthrough acetylcholinesterase in the pathophysiology of myasthenia gravis","volume":"17","author":"Brenner","year":"2003","journal-title":"FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0060","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1172\/JCI113807","article-title":"In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes","volume":"82","author":"Brocke","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0065","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0165-5728(88)90003-3","article-title":"Clonotypic analysis of the antibody response to the acetylcholine receptor in experimental autoimmune myasthenia gravis","volume":"19","author":"Brown","year":"1988","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0070","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.4049\/jimmunol.128.5.2228","article-title":"Lymphocyte activation in experimental autoimmune myasthenia gravis","volume":"128","author":"De Baets","year":"1982","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0075","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/BF02918135","article-title":"Effects of the rate of acetylcholine receptor synthesis on the severity of experimental autoimmune myasthenia gravis","volume":"7","author":"De Baets","year":"1988","journal-title":"Immunol. Res."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0080","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00000542-200301000-00022","article-title":"Pharmacokinetic\u2013pharmacodynamic modeling of rocuronium in case of a decreased number of acetylcholine receptors: a study in myasthenic pigs","volume":"98","author":"De Haes","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1016\/j.expneurol.2015.03.010_bb0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0090-1229(88)90154-7","article-title":"Treatment of experimental myasthenia gravis with total lymphoid irradiation","volume":"48","author":"de Silva","year":"1988","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0090","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0197-0186(83)90074-8","article-title":"Biochemical and electrophysiological properties of antibodies against pure acetylcholine receptor from vertebrate muscles and its subunits from Torpedo in relation to experimental myasthenia","volume":"5","author":"Dolly","year":"1983","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0095","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0090-1229(85)90022-4","article-title":"Treatment of experimental myasthenia gravis with cyclosporin A","volume":"34","author":"Drachman","year":"1985","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0100","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/jaut.2002.0618","article-title":"Anti-TNF-alpha antibodies suppress the development of experimental autoimmune myasthenia gravis","volume":"19","author":"Duan","year":"2002","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0105","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1023\/A:1022572727408","article-title":"Dehydroepiandrosterone therapy ameliorates experimental autoimmune myasthenia gravis in Lewis rats","volume":"23","author":"Duan","year":"2003","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0110","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1016\/S0041-1345(02)03504-2","article-title":"The immunosuppressant LF 15-0195 prevents experimental autoimmune myasthenia gravis in Brown-Norway rats","volume":"34","author":"Duplan","year":"2002","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0022-510X(83)90085-0","article-title":"Morphological changes observed in rats immunized with the Torpedo acetylcholine receptor alpha-chain","volume":"59","author":"Elfman","year":"1983","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0120","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00005072-197609000-00008","article-title":"Experimental autoimmune myasthenia gravis: a sequential and quantitative study of the neuromuscular junction ultrastructure and electrophysiologic correlations","volume":"35","author":"Engel","year":"1976","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0125","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1212\/WNL.27.4.307","article-title":"Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model","volume":"27","author":"Engel","year":"1977","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2015.03.010_bb0130","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.4049\/jimmunol.140.6.1830","article-title":"Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides","volume":"140","author":"Fujii","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0135","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/00005072-198211000-00001","article-title":"Ultrastructural aspects of acetylcholine receptor turnover at the normal end-plate and in autoimmune myasthenia gravis","volume":"41","author":"Fumagalli","year":"1982","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0140","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0165-2478(80)90002-4","article-title":"Differences in the ability of rat IgG subclasses to consume complement in homologous and heterologous serum","volume":"1","author":"F\u00fcst","year":"1980","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0145","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/08916930903555943","article-title":"Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction","volume":"43","author":"Gomez","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.expneurol.2015.03.010_bb0150","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.4049\/jimmunol.1002539","article-title":"Proteasome inhibition with bortezomib depletes plasma cells and autoantibodies in experimental autoimmune myasthenia gravis","volume":"186","author":"Gomez","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0155","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1749-6632.2012.06824.x","article-title":"Targeting plasma cells with proteasome inhibitors: possible roles in treating myasthenia gravis?","volume":"1274","author":"Gomez","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0160","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.4049\/jimmunol.150.9.4093","article-title":"Age-related resistance to experimental autoimmune myasthenia gravis in rats","volume":"150","author":"Graus","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0165","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1365-2249.1997.d01-881.x","article-title":"Age- and sex-related resistance to chronic experimental autoimmune myasthenia gravis (EAMG) in Brown Norway rats","volume":"107","author":"Hoedemaekers","year":"1997","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0170","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/(SICI)1097-4598(199709)20:9<1091::AID-MUS1>3.0.CO;2-3","article-title":"Age-related susceptibility to experimental autoimmune myasthenia gravis: immunological and electrophysiological aspects","volume":"20","author":"Hoedemaekers","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2015.03.010_bb0175","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0165-5728(98)00126-X","article-title":"Role of the target organ in determining susceptibility to experimental autoimmune myasthenia gravis","volume":"89","author":"Hoedemaekers","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0180","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.4049\/jimmunol.126.4.1355","article-title":"Autoimmune rat T lymphocytes monospecific for acetylcholine receptors: purification and fine specificity","volume":"126","author":"Hohlfeld","year":"1981","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0185","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/BF00590199","article-title":"Neuromuscular Transmission in experimental autoimmune myasthenia gravis (EAMG). Quantitative ionophoresis and current fluctuation analysis at normal and myasthenic rat end-plates","volume":"390","author":"Hohlfeld","year":"1981","journal-title":"Arch. Eur. J. Physiol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0190","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1096\/fj.01-0072com","article-title":"Suppression of experimental myasthenia gravis, a B cell-mediated autoimmune disease, by blockade of IL-18","volume":"15","author":"Im","year":"2001","journal-title":"FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0195","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0022-510X(92)90153-C","article-title":"Suppression of experimental autoimmune myasthenia gravis with new immunosuppressants: 15-deoxyspergualin and actinobolin","volume":"112","author":"Ishigaki","year":"1992","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0200","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jneuroim.2008.05.029","article-title":"Immunosuppression of experimental autoimmune myasthenia gravis by mycophenolate mofetil","volume":"201\u2013202","author":"Janssen","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0205","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0165-5728(94)90009-4","article-title":"Immunomodulation of experimental autoimmune myasthenia gravis with linomide","volume":"55","author":"Karussis","year":"1994","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0210","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ana.410040113","article-title":"Acetylcholine release in diaphragm of rats with chronic experimental autoimmune myasthenia gravis","volume":"4","author":"Kelly","year":"1978","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0215","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.4049\/jimmunol.133.5.2549","article-title":"Specific killing of lymphocytes that cause experimental autoimmune myasthenia gravis by ricin toxin\u2013acetylcholine receptor conjugates","volume":"133","author":"Killen","year":"1984","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0220","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0022-510X(79)90041-8","article-title":"Short-term effects of prednisolone on neuromuscular transmission in normal rats and those with experimental autoimmune myasthenia gravis","volume":"41","author":"Kim","year":"1979","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0225","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/mus.880030203","article-title":"Facilitatory effects of 4-aminopyridine on neuromuscular transmission in disease states","volume":"3","author":"Kim","year":"1980","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2015.03.010_bb0230","series-title":"Electrodiagnosis in Disease of Nerve and Muscle: Principles and Practice","author":"Kimura","year":"2001"},{"key":"10.1016\/j.expneurol.2015.03.010_bb0235","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/eji.200838729","article-title":"BM stromal cells ameliorate experimental autoimmune myasthenia gravis by altering the balance of Th cells through the secretion of IDO","volume":"39","author":"Kong","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0240","series-title":"The Laboratory Rat","first-page":"133","article-title":"Control of SPF conditions: FELASA standards","author":"Kunstyr","year":"2000"},{"key":"10.1016\/j.expneurol.2015.03.010_bb0245","doi-asserted-by":"crossref","first-page":"e102231","DOI":"10.1371\/journal.pone.0102231","article-title":"Survivin as a potential mediator to support autoreactive cell survival in myasthenia gravis: a human and animal model study","volume":"9","author":"Kusner","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.expneurol.2015.03.010_bb0250","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1084\/jem.141.6.1365","article-title":"Experimental autoimmune myasthenia: a model of myasthenia gravis in rats and guinea pigs","volume":"141","author":"Lennon","year":"1975","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0255","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1084\/jem.147.4.973","article-title":"Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis","volume":"147","author":"Lennon","year":"1978","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0260","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.4049\/jimmunol.146.7.2245","article-title":"Recombinant human acetylcholine receptor alpha-subunit induces chronic experimental autoimmune myasthenia gravis","volume":"146","author":"Lennon","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0265","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/clin.1997.4495","article-title":"Nasal tolerance to experimental autoimmune myasthenia gravis: tolerance reversal by nasal administration of minute amounts of interferon-gamma","volume":"87","author":"Li","year":"1998","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0270","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF02873581","article-title":"Experimental study on induction of tolerance to experimental autoimmune myasthenia gravis by immature dendritic cells","volume":"25","author":"Li","year":"2005","journal-title":"J. Huazhong Univ. Sci. Technolog. Med. Sci."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0275","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1084\/jem.144.3.726","volume":"144","author":"Lindstrom","year":"1976","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0280","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.4049\/jimmunol.178.8.5390","article-title":"Amelioration of experimental autoimmune myasthenia gravis in rats by neonatal FcR blockade","volume":"178","author":"Liu","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0285","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1093\/brain\/awh612","article-title":"Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis","volume":"128","author":"Losen","year":"2005","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0290","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1002\/eji.1830220939","article-title":"Passive transfer of experimental myasthenia gravis via antigenic modulation of acetylcholine receptor","volume":"22","author":"Loutrari","year":"1992","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0295","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/08916934.2011.622015","article-title":"Myasthenogenicity of the main immunogenic region and endogenous muscle nicotinic acetylcholine receptors","volume":"45","author":"Luo","year":"2012","journal-title":"Autoimmunity"},{"key":"10.1016\/j.expneurol.2015.03.010_bb0300","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.4049\/jimmunol.1401392","article-title":"Antigen-specific immunotherapeutic vaccine for experimental autoimmune myasthenia gravis","volume":"193","author":"Luo","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0305","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0165-5728(94)00187-S","article-title":"Suppression of experimental autoimmune myasthenia gravis by nasal administration of acetylcholine receptor","volume":"58","author":"Ma","year":"1995","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0310","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jneuroim.2004.04.010","article-title":"Immunosuppression of rat myasthenia gravis by oral administration of a syngeneic acetylcholine receptor fragment","volume":"152","author":"Maiti","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0315","doi-asserted-by":"crossref","first-page":"644","DOI":"10.2353\/ajpath.2007.060676","article-title":"Overexpression of rapsyn in rat muscle increases acetylcholine receptor levels in chronic experimental autoimmune myasthenia gravis","volume":"170","author":"Martinez-Martinez","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0320","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/cimm.1995.0012","article-title":"Immunosuppression and induction of anergy by CTLA4Ig in vitro: effects on cellular and antibody responses of lymphocytes from rats with experimental autoimmune myasthenia gravis","volume":"166","author":"McIntosh","year":"1995","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0325","first-page":"171","article-title":"Classes and subclasses of rat antibodies: reaction with the antigen and interaction of the complex with the complement system","volume":"43","author":"Medgyesi","year":"1981","journal-title":"Immunology"},{"key":"10.1016\/j.expneurol.2015.03.010_bb0330","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jneuroim.2008.05.023","article-title":"Suppression of experimental autoimmune myasthenia gravis by combination therapy: pentoxifylline as a steroid-sparing agent","volume":"201\u2013202","author":"Menon","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0335","doi-asserted-by":"crossref","first-page":"6328","DOI":"10.1016\/S0021-9258(18)50366-5","article-title":"Degradation of acetylcholine receptor in diaphragms of rats with experimental autoimmune myasthenia gravis","volume":"254","author":"Merlie","year":"1979","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0340","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jneuroim.2006.07.004","article-title":"CD4+ T and B cells cooperate in the immunoregulation of experimental autoimmune myasthenia gravis","volume":"179","author":"Milani","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0345","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0079-6123(08)64657-9","article-title":"Acetylcholine in intercostal muscle from myasthenia gravis patients and in rat diaphragm after blockade of acetylcholine receptors","volume":"49","author":"Molenaar","year":"1979","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0350","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2826.2004.01173.x","article-title":"Effect of environmental enrichment on stress related systems in rats","volume":"16","author":"Moncek","year":"2004","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0355","doi-asserted-by":"crossref","first-page":"C53","DOI":"10.1152\/ajpcell.1979.236.1.C53","article-title":"Myasthenia in frogs immunized against cholinergic-receptor protein","volume":"236","author":"Nastuk","year":"1979","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0360","series-title":"Guide for the Care and Use of Laboratory Animals","author":"National Research Council (U.S.). Committee for the Update of the Guide for the Care and Use of Laboratory Animals","year":"2011"},{"key":"10.1016\/j.expneurol.2015.03.010_bb0365","doi-asserted-by":"crossref","first-page":"e84791","DOI":"10.1371\/journal.pone.0084791","article-title":"Expression of a highly antigenic and native-like folded extracellular domain of the human alpha1 subunit of muscle nicotinic acetylcholine receptor, suitable for use in antigen specific therapies for myasthenia gravis","volume":"8","author":"Niarchos","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.expneurol.2015.03.010_bb0370","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.410080105","article-title":"Lymphocyte responsiveness to acetylcholine receptor in rats with experimental autoimmune myasthenia gravis","volume":"8","author":"Noguchi","year":"1980","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0375","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ana.410360504","article-title":"Oral administration of acetylcholine receptor: effects on experimental myasthenia gravis","volume":"36","author":"Okumura","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0380","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.4049\/jimmunol.135.5.3062","article-title":"Selective in vitro inhibition of an antibody response to purified acetylcholine receptor by using antigen\u2013ricin A chain immunotoxin","volume":"135","author":"Olsberg","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0385","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0165-5728(87)90013-0","article-title":"Analysis of contractile properties of muscles from rats immunized with purified acetylcholine receptor","volume":"14","author":"Olsberg","year":"1987","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0390","first-page":"1215","article-title":"A shared epitope in the acetylcholine receptor-alpha subunit and fast troponin I of skeletal muscle. Is it important for myasthenia gravis?","volume":"140","author":"Osborn","year":"1992","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0395","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.180.4088.871","article-title":"Autoimmune response to acetylcholine receptor","volume":"180","author":"Patrick","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2015.03.010_bb0400","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ana.410140210","article-title":"Combined short-term immunotherapy for experimental autoimmune myasthenia gravis","volume":"14","author":"Pestronk","year":"1983","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0405","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2004-829593","article-title":"The epidemiology of myasthenia gravis","volume":"24","author":"Phillips","year":"2004","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0410","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/ana.410370513","article-title":"Acetylcholine release in myasthenia gravis: regulation at single end-plate level","volume":"37","author":"Plomp","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0415","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ana.410430315","article-title":"End-plate voltage-gated sodium channels are lost in clinical and experimental myasthenia gravis","volume":"43","author":"Ruff","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0420","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00005072-197803000-00008","article-title":"Ultrastructural localization of immune complexes (IgG and C3) at the end-plate in experimental autoimmune myasthenia gravis","volume":"37","author":"Sahashi","year":"1978","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0425","doi-asserted-by":"crossref","first-page":"7189","DOI":"10.4049\/jimmunol.162.12.7189","article-title":"Experimental autoimmune myasthenia gravis may occur in the context of a polarized Th1- or Th2-type immune response in rats","volume":"162","author":"Saoudi","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0430","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ana.21536","article-title":"Novel complement inhibitor limits severity of experimentally myasthenia gravis","volume":"65","author":"Soltys","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0435","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.neuron.2014.10.042","article-title":"Rigor or mortis: best practices for preclinical research in neuroscience","volume":"84","author":"Steward","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2015.03.010_bb0440","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0022-510X(84)90013-3","article-title":"Presynaptic function modified by acetylcholine\u2013receptor interaction in experimental autoimmune myasthenia gravis","volume":"66","author":"Takamori","year":"1984","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0445","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/256128a0","article-title":"Experimental autoimmune myasthenia induced in monkeys by purified acetylcholine receptor","volume":"256","author":"Tarrab-Hazdai","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2015.03.010_bb0450","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/mus.880150116","article-title":"Repetitive nerve stimulation vs. twitch tension in rats with EAMG","volume":"15","author":"Thompson","year":"1992","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2015.03.010_bb0455","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.4049\/jimmunol.180.4.2696","article-title":"Pixantrone (BBR2778) reduces the severity of experimental autoimmune myasthenia gravis in Lewis rats","volume":"180","author":"Ubiali","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0460","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/mus.880130604","article-title":"Single-fiber electromyography in experimental autoimmune myasthenia gravis","volume":"13","author":"Verschuuren","year":"1990","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2015.03.010_bb0465","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0165-5728(93)90045-Z","article-title":"Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor","volume":"44","author":"Wang","year":"1993","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0470","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1006\/cimm.1993.1300","article-title":"T cell reactivity to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis","volume":"152","author":"Wang","year":"1993","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0475","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1006\/cimm.1994.1233","article-title":"Induction of interferon-gamma, interleukin-4, and transforming growth factor-beta in rats orally tolerized against experimental autoimmune myasthenia gravis","volume":"157","author":"Wang","year":"1994","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0480","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1002\/eji.1830261210","article-title":"Inhibition of experimental autoimmune myasthenia gravis by major histocompatibility complex class II competitor peptides results not only in a suppressed but also in an altered immune response","volume":"26","author":"Wauben","year":"1996","journal-title":"Eur. J. Immunol."},{"issue":"Pt 1","key":"10.1016\/j.expneurol.2015.03.010_bb0485","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1113\/jphysiol.1997.sp022007","article-title":"The contribution of postsynaptic folds to the safety factor for neuromuscular transmission in rat fast- and slow-twitch muscles","volume":"500","author":"Wood","year":"1997","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0490","series-title":"Current Protocols in Immunology","article-title":"Experimental autoimmune myasthenia gravis in the mouse","author":"Wu","year":"2001"},{"key":"10.1016\/j.expneurol.2015.03.010_bb0495","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0008-8749(03)00118-7","article-title":"Induction of peripheral tolerance to experimental autoimmune myasthenia gravis by acetylcholine receptor-pulsed dendritic cells","volume":"223","author":"Xiao","year":"2003","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0500","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/cimm.2001.1777","article-title":"Prevention and reversal of experimental autoimmune myasthenia gravis by a monoclonal antibody against acetylcholine receptor-specific T cells","volume":"208","author":"Xu","year":"2001","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0505","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1365-2249.2002.01748.x","article-title":"Dendritic cells exposed in vitro to TGF-beta1 ameliorate experimental autoimmune myasthenia gravis","volume":"127","author":"Yarilin","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0510","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.molimm.2008.08.264","article-title":"Suppression of experimental myasthenia gravis by a B-cell epitope-free recombinant acetylcholine receptor","volume":"46","author":"Yi","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0515","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/jaut.1996.0111","article-title":"FK506 prevents induction of rat experimental autoimmune myasthenia gravis","volume":"10","author":"Yoshikawa","year":"1997","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0520","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0014-4886(83)90022-5","article-title":"Reduction of miniature end-plate potential amplitude in extraocular and limb muscles in an animal model of myasthenia gravis","volume":"80","author":"Zahm","year":"1983","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0525","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/eji.1830180410","article-title":"T cell epitopes in experimental autoimmune myasthenia gravis of the rat: strain-specific epitopes and cross-reaction between two distinct segments of the alpha chain of the nicotinic acetylcholine receptor (Torpedo californica)","volume":"18","author":"Zhang","year":"1988","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0530","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1084\/jem.184.2.349","article-title":"Both CD4+ and CD8+ T cells are essential to induce experimental autoimmune myasthenia gravis","volume":"184","author":"Zhang","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0535","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0165-5728(96)00197-X","article-title":"Linomide suppresses both Th1 and Th2 cytokines in experimental autoimmune myasthenia gravis","volume":"73","author":"Zhang","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0540","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jneuroim.2006.04.011","article-title":"Intravenous immunoglobulin suppresses experimental myasthenia gravis: immunological mechanisms","volume":"176","author":"Zhu","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2015.03.010_bb0545","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0165-5728(93)90083-B","article-title":"Antigen presentation and T cell specificity repertoire in determining responsiveness to an epitope important in experimental autoimmune myasthenia gravis","volume":"43","author":"Zoda","year":"1993","journal-title":"J. Neuroimmunol."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488615000783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488615000783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:48:48Z","timestamp":1691542128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488615000783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":109,"alternative-id":["S0014488615000783"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2015.03.010","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors \u2014 Recommendations for methods and experimental designs","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2015.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}